In 2020, the generic drugs market reached a global value of $386 billion. Over the next several years, it is expected to increase. Experts predict that the generic drug market will grow at a compound annual growth rate (CGAR) of 5.7 percent, meaning it will be valued at over $675 billion by 2030.

Generic drugs are developed using the same active ingredients as branded drugs and provide an equal therapeutic effect. In addition, generic drugs are identical when it comes to quality, dosage, strength, safety, intended use, and side effects.

Cost Benefits of Generic Drugs
Generic drugs can only be produced after the patent of a brand-name drug expires. Once this happens, pharmaceutical manufacturers can reproduce brand-name drugs as generic for a lower cost because they do not need to go through the process of studying the medicine’s effects on humans or animals before going on the market.

Because the upfront costs of research are substantially lower, generic drugs are usually sold on the market for a significantly lower price than branded drugs.

Recent government reimbursement programs have favored lower-cost options, leading to a price war that leaves some generic drug companies with razor-thin margins. To stay competitive, many generic drug manufacturers have needed to find ways to add more value to their products. So-called “super generics” improve the delivery system or reformulate the drug to produce a better product for patients.

Generic Drug Market Trends and Opportunities
Here are some trends and opportunities to watch for in the coming years for the generic drugs market.

Increased use of generics in developing countries
Developing and impoverished countries face healthcare shortages, including medication. The lower cost of generics can make getting access to essential medicines more feasible and accessible for the people living in these countries.

Even so, there has still been a shortage of generic medicines available to distribute to poorer areas. In the next few years, we should expect to see the global generic market grow as companies like  SK-Pharma launch with the goal of making generic medicines accessible to more people.

Streamlined regulatory compliance
A significant hurdle for introducing generic medicines to new markets is regulatory barriers, including requiring vast amounts of evidence before products can be approved.

To keep generics on the market, pharmaceutical companies will need to develop new, innovative methods for streamlining compliance to expedite development and distribution.

Need to balance a global and local supply chain
Nearly every industry has experienced supply chain disruptions in the wake of the COVID-19 pandemic, and the pharmaceutical industry is no exception.

“Knowing the peculiarity of each market is of a vital importance. What’s correct for Europe probably won’t be the case in Russia. Incentives and reimbursement for Covid-19 drugs is changing rapidly, staying a head of the upcoming trends, can have significant impact”.

To stay competitive, pharma manufacturers will need to balance their local and global supply chains while keeping up with evolving environmental and sustainability requirements.

Bottom Line
Over the next five years, we should expect to see an increase in the development and distribution of generic medicines to all parts of the world.

As more patents expire on branded drugs and the Food and Drug Administration (FDA) makes the market entry process for generics more efficient, we should expect to see more generic medications making their way to the market.

References
Barei, F., Pen, C. L., & Simoens, S. (2013). The generic pharmaceutical industry: Moving Beyond Incremental Innovation towards re-innovation. GaBI Journal. Retrieved November 8, 2021, from http://gabi-journal.net/the-generic-pharmaceutical-industry-moving-beyond-incremental-innovation-towards-re-innovation.html.

Generic Drugs Market (drug type: Simple generics and Super Generics; by brand: Pure Generic Drugs and branded generic drugs; by route of Drug Administration: Oral, topical, parental, and others; by Therapeutic Application: Central Nervous System (CNS), cardiovascular, dermatology, oncology, respiratory, and others; by Distribution Channel: Hospitals Pharmacies, retail pharmacies, and others) – global industry analysis, market size, share, growth, trends, Region Outlook, and segment forecasts, 2021 – 2030. Precedence Research. (n.d.). Retrieved November 8, 2021, from https://www.precedenceresearch.com/generic-drugs-market.

Home: SK-Pharma is a global pharmaceutical company focusing on early genericism of

           valuable medicinal products worldwide. Our mission is to improve wellbeing by allowing

           accessible medicines to all patients in needs. (2021, June 15). Retrieved November 8,

            2021, from https://sk-pharma.com